CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 207 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $694,428 | +66.4% | 29,400 | +5.0% | 0.00% | 0.0% |
| Q3 2023 | $417,331 | +36.8% | 27,990 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $304,958 | +548.8% | 27,850 | +83.0% | 0.00% | – |
| Q1 2022 | $47,000 | -7.8% | 15,220 | 0.0% | 0.00% | – |
| Q4 2021 | $51,000 | -7.3% | 15,220 | +1.2% | 0.00% | – |
| Q3 2021 | $55,000 | -16.7% | 15,045 | 0.0% | 0.00% | – |
| Q2 2021 | $66,000 | 0.0% | 15,045 | +3.1% | 0.00% | – |
| Q1 2021 | $66,000 | -21.4% | 14,594 | 0.0% | 0.00% | – |
| Q4 2020 | $84,000 | -20.8% | 14,594 | 0.0% | 0.00% | – |
| Q3 2020 | $106,000 | +107.8% | 14,594 | 0.0% | 0.00% | – |
| Q2 2020 | $51,000 | +183.3% | 14,594 | +20.0% | 0.00% | – |
| Q1 2020 | $18,000 | -25.0% | 12,164 | -2.0% | 0.00% | – |
| Q4 2019 | $24,000 | -62.5% | 12,414 | 0.0% | 0.00% | – |
| Q3 2019 | $64,000 | -28.1% | 12,414 | 0.0% | 0.00% | – |
| Q2 2019 | $89,000 | -45.1% | 12,414 | +1.5% | 0.00% | – |
| Q1 2019 | $162,000 | +68.8% | 12,234 | 0.0% | 0.00% | – |
| Q4 2018 | $96,000 | -28.4% | 12,234 | +1.2% | 0.00% | – |
| Q3 2018 | $134,000 | -7.6% | 12,090 | +11.8% | 0.00% | – |
| Q2 2018 | $145,000 | – | 10,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |